Fermelanta

Engineer cell factories capable of making valuable compounds accessible to all.

Nonoichi, Japan · Founded 2022 · $12.6M raised

Headquarters
Nonoichi
Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$12.6M
Last Round
$12.6M Series ASep 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Fermelanta, Inc. is a Japan-based synthetic biology and biomanufacturing startup that engineers microbial cell factories to produce rare, high-value plant-derived compounds via precision fermentation. The company's proprietary platform introduces over 20 genes into highly productive E. coli, enabling biosynthesis of complex phytochemicals — including morphine precursors — that are costly or impractical to extract from plants. Fermelanta serves the dietary supplements, functional foods, pharmaceutical, and cosmetics markets with scalable, sustainable alternatives to plant extraction and petrochemical processes.

Summary

Fermelanta is a Biotech company based in Nonoichi, Japan, founded in 2022. It has raised $12.6M in total across 1 round, most recently a $12.6M Series A round in Sep 2025.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ASep 2025
$12.6M

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Fermelanta on Indexed.vc
<a href="https://indexed.vc/companies/fermelanta"><img src="https://indexed.vc/api/badge/company/fermelanta" alt="Fermelanta on Indexed.vc" width="260" height="76" /></a>